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Abstract
Introduction: Operation on the infrarenal aorta and large arteries of the lower extremities may cause rhabdomyolysis of the
skeletal muscle, which in turn may induce remote kidney injury. NIM-811 (N-metyl-4-isoleucine-cyclosporine) is a
mitochondria specific drug, which can prevent ischemic-reperfusion (IR) injury, by inhibiting mitochondrial permeability
transition pores (mPTP).
Objectives: Our aim was to reduce damages in the skeletal muscle and the kidney after IR of the lower limb with NIM-811.
Materials and methods: Wistar rats underwent 180 minutes of bilateral lower limb ischemia and 240 minutes of
reperfusion. Four animal groups were formed called Sham (receiving vehicle and sham surgery), NIM-Sham (receiving NIM-
811 and sham surgery), IR (receiving vehicle and surgery), and NIM-IR (receiving NIM-811 and surgery). Serum, urine and
histological samples were taken at the end of reperfusion. NADH-tetrazolium staining, muscle Wet/Dry (W/D) ratio
calculations, laser Doppler-flowmetry (LDF) and mean arterial pressure (MAP) monitoring were performed. Renal
peroxynitrite concentration, serum TNF-a and IL-6 levels were measured.
Results: Less significant histopathological changes were observable in the NIM-IR group as compared with the IR group.
Serum K+ and necroenzyme levels were significantly lower in the NIM-IR group than in the IR group (LDH: p,0.001; CK: p,
0.001; K+: p = 0.017). Muscle mitochondrial viability proved to be significantly higher (p = 0.001) and renal function
parameters were significantly better (creatinine: p = 0.016; FENa: p,0.001) in the NIM-IR group in comparison to the IR
group. Serum TNF-a and IL-6 levels were significantly lower (TNF-a: p = 0.003, IL-6: p = 0.040) as well as W/D ratio and
peroxynitrite concentration were significantly lower (p = 0.014; p,0.001) in the NIM-IR group than in the IR group.
Conclusion: NIM-811 could have the potential of reducing rhabdomyolysis and impairment of the kidney after lower limb IR
injury.
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Introduction
Arterial occlusive diseases are the most frequent causes of acute
limb ischemia (ALI). Operative treatments for these diseases, as
well as other reconstructive surgeries on abdominal aorta or other
major arteries of the lower limb may induce sudden onset
ischemia, in which event lower limb tissues suffer ischemic-
reperfusion (IR) injuries.
There are two sides to IR injury since, in a paradox manner,
reestablishment of the blood supply is associated with further
damages. Beyond local muscle cell necrosis and consequent
rhabdomyolysis, serious remote organ injuries may also develop.
The metabolites and proinflammatory cytokines released from the
damaged muscles [1–3] may induce systemic inflammatory
response syndrome (SIRS), which could possibly affect the
gastrointestinal system, lungs and kidneys, thereby inducing
multiple organ dysfunction syndrome (MODS).
Mitochondria play a leading role in IR injury [4]. Damage
caused by mitochondrial membrane depolarization can signifi-
cantly jeopardize energy production, which can lead to cell
damage, then further to cell death. The mechanism of mitochon-
drial membrane depolarization, called mitochondrial permeability
transition (MPT), is induced by the opening of the mitochondrial
permeability transition pores (mPTP) in the mitochondrial
membrane [5]. Several proteins participate in the structure of
the pore, but the most important during mPTP opening is
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cyclophilin-D in the mitochondrial matrix [6,7]. After opening of
the pore, the mitochondrial electron transport chain is interrupted,
which disarrays mitochondrial energy production and induces
production of reactive oxygen species (ROS) [6]. Decline of the
mitochondrial membrane potential causes further opening of the
mPTPs, thus release of different molecules from the dysfunctional
mitochondria may provoke cell death [6].
Cyclosporine-A (CsA) – besides its known immunosuppressive
effects – is a potential inhibitor of the opening of mPTP. It can
bind to both the cyclophilin-D component of mPTPs and the
cytosolic cyclophilin-A molecules [8–11]. N-methyl-4-isoleucine
cyclosporine (NIM-811) is a derivative of CsA, which does not
bind to cyclophilin-A, therefore it has no immunosuppressive
effects; it does however inhibit the opening of mPTP by binding to
cyclophilin-D, thus preventing the development of MPT [12].
NIM-811 has an enormous advantage over CsA in that it has no
known systemic side effects.
Based on our earlier investigations, attenuation of local IR
damage can reduce the risk of remote organ injury (i. e. in the
kidneys) [13–15]. During IR, opening of the mPTP plays a pivotal
role in cell injury, thus inhibition of the pore opening may mitigate
the damages. In the current study therefore, our aim was to
examine the potentially favourable effects of NIM-811 as an
inhibitor of mPTP opening in a skeletal muscle model of IR injury,
with respect to local damages, consequential remote organ
complications, as well as renal dysfunction.
Materials and Methods
Male Wistar rats (n = 40) weighing 220–250 g were used
(Charles Rivers Hungary Ltd., Budapest, Hungary). Animals were
kept under specific pathogen-free conditions at 22–24uC, on
standard rat chow and water ‘ad libitum’. The experimental
design was carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health (The National Academies
Press, Washington, D.C., USA, 8th edition). The protocol was
approved by the Committee on Animal Experimentation of
Semmelweis University (Permit Number: 22.1/2409/3/2011). All
surgeries were performed under general anesthesia with efforts to
minimize suffering.
Preoperative procedures
Animals were anesthetized by intraperitoneal injection of
75 mg/bwkg ketamine and 7.5 mg/bwkg xylazine. Anesthesia
was maintained by intravenous (through right jugular vein)
administration of 25 mg/bwkg/h ketamine and 2.5 mg/bwkg/h
xylazine. Heating blankets were used to keep body temperature at
37uC 60.5uC, monitored with rectal probe (Homeothermic
Blanket Control Unit, Harvard Apparatus, Holliston, MA, USA).
Mean arterial pressure (MAP) was registered by invasive blood
pressure monitor (Kent Scientific Corporation, Torrington, CT,
USA) through the internal carotid artery.
Surgical procedures and experimental design
Before induction of ischemia, a 20-minute baseline period was
allowed. Tourniquet was applied around both lower limbs in the
femoral region [16], and rats underwent a 180-minute long total
bilateral lower limb ischemia. After median laparotomy, a laser-
Doppler flowmeter (LDF) probe was placed over the front surface
of the left kidney in order to monitor circulation of the renal
parenchyma [17]. Following a 1 cm longitudinal skin incision
along the lateral side of the thigh, another LDF probe was placed
on the femoral biceps muscle to monitor the microcirculation of
the left lower limb [14].
The animals were randomized to the following four groups
according to treatment: Sham (receiving vehicle and sham surgery,
n = 10), NIM-Sham (receiving NIM-811 and sham surgery,
n = 10), IR (receiving vehicle and surgery, n = 10) and NIM-IR
(receiving NIM-811 and surgery, n = 10). Five minutes before
reperfusion, NIM-811 (10 mg/bwkg; Novartis International AG,
Basel, Switzerland) was administered intravenously to the NIM-
Sham and NIM-IR groups. After removal of the tourniquet,
reperfusion was allowed for 240 minutes. Sham animals received
all procedures including anesthesia and laparotomy except for the
180-minute-long ischemia.
During the experiment, urine output was determined by
gathering the spontaneously excreted urine in two fractions: (1)
urine samples collected for 20 minutes before the ischemia served
as control; (2) the amount of urine gathered during the last 3 hours
of reperfusion was completed with bladder puncture at termina-
tion of the experiment.
Determining skeletal muscle injury
Serum laboratory parameters. Tests consisted of measur-
ing serum creatine kinase (CK), lactate dehydrogenase (LDH) and
K+ levels. After centrifuging (2610 min, 1050 g) the blood
samples, serum was snap-frozen in liquid nitrogen and stored at
280uC until analysed with a clinical chemistry analyzer automate
(Beckman Coulter AU480/2011, Beckman Coulter Inc, Brea, CA,
USA).
Histological evaluation of skeletal muscle. Samples were
collected from the anterior tibial muscle and fixed in 4% neutral
buffered formalin solution for one day. Thereafter samples were
embedded in paraffin, 3 mm thin cross- and longitudinal sections
were cut and stained for hematoxillin and eosin. Histological
examinations were carried out with Olympus BX50 microscope
equipped with Olympus DP70 camera (Olympus Corporation,
Tokyo, Japan). The examining pathologist received no informed
about the applied pretreatment.
Assessment of muscle fiber viability. Samples from the
left anterior tibial muscle were snap frozen in liquid nitrogen and
stored at 280uC until further processing. Cross sections of 3 mm
thickness were cut in cryostat. Slides were incubated for 30
minutes at 37uC in a solution consisting of nitroblue tetrazolium
(1.8 mg/dL), NADH (15 mg/dL) and 0.05 M TRIS buffer
(pH 7.6) (Sigma-Aldrich Inc, St. Louis, MO, USA). Unused
tetrazolium reagent was removed using ascending and descending
concentrations of acetone. Ten different fields were photographed
randomly in each slide with 6006 magnification. Viability
assessment was performed by detection of NADH-tetrazolium
reductase staining of muscles using Leica QWin Pro (Leica
Microsystems Ltd, Wetzlar, Germany) morphometric software.
Muscle fiber viability was calculated as a proportion of the total
stained area and the total muscle fiber area of the slide. Average of
the 10 slides was calculated for each animal. The final result is
expressed as a percentage of the values of untreated control
muscles (obtained in a previous experiment) [18].
Skeletal muscle Wet/Dry (W/D) ratio. Tissue edema was
quantified with the wet/dry ratio utilizing the remaining tibial
anterior muscle. Following careful excision, muscles were weighed
immediately after the end of reperfusion (wet weight) and placed in
a drying oven set at a temperature of +80uC until reaching
constant weight. Muscles were then reweighed (dry weight) [19]
and wet/dry ratio calculated using the following equation: (wet
weight – dry weight)/wet weight * 100.
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Measurement of tissue microcirculation. Registration of
microcirculation of the lower limb skeletal muscle was performed
by laser Doppler flowmeter (MOOR Instruments Ltd, London,
UK; DRT4). The probe of the device was placed on the surface of
the left femoral biceps muscle. To characterize the microcircula-
tion, reperfusion area (RA) was used, based on the mathematical
calculations of our research group. The mathematical transfor-
mations required for correct interpretation of the circulation data
were described previously [20].
Systemic inflammatory parameters
Measurement of TNF-a and IL-6 levels. Proinflammatory
cytokine concentrations were measured by sandwich ELISA kits
according to manufacturer’s instructions (R&D Systems, Minne-
apolis, MN, USA). Absorbance was measured at 450nm.
Determination of kidney dysfunction
Histopathology. Tissue sampling was performed from the
same anatomical location (left kidney) in case of every animal,
regardless of group. As in case of skeletal muscle samples, kidney
samples were fixed in 4% neutral buffered formalin solution (24 h),
followed by embedment in paraffin, then 3 mm thin sections were
cut and stained for hematoxillin and eosin. During evaluation of
the sections (Olympus DP70 camera, Olympus Corporation,
Tokyo, Japan), features of tubular and interstitial injuries were
considered.
Evaluation of histological damage was performed in keeping
with a score described previously [21]. The degree of tubular
damage to the kidney tissue was scored by determining the
percentage of tubules in the kidney cortex, which showed tubular
damage, tubular cell necrosis and cast formation as follows: 0,
none; 1#10%; 2, 10–25%; 3, 25–45%; 4, 45–75%; 5.75%. Ten
randomly chosen, non-overlapping fields per section were
examined. Scoring was carried out by an independent pathologist
in a blinded manner.
Laboratory examinations. Blood samples were investigated
according to the same method as serum necroenzymes. Levels of
Na+-, creatinine- and BUN (blood urea nitrogen) were deter-
mined, from which renal injury parameters (BUN/creatinine
ratio, fractional Na+-excretion (FENa = UNa+6Pkreat. x100/Uk-
reat.6PNa+) were calculated.
Registration of renal microcirculation. During the exper-
iment, microcirculation of the left kidney cortex was registered
with LDF, placing the laser probe on the anterior surface of the left
kidney.
Measurement of peroxynitrite concentrations in the
kidneys. Homogenized samples of kidney tissue were analyzed
by spectrophotometric method after dilution in 1.0 M NaOH
(60:1) solution; absorbance was measured at 302 nm. As control,
100 mM potassium-phosphate (pH 7.4) was added to the sample
(60:1). The rate of decline in absorbance was measured on neutral
pH [22].
Biochemicals
NIM-811 was the generous gift of Novartis International AG
(Basel, Switzerland). The agent (10 mg/bwkg) was dissolved in the
vehicle, which contained 1.3 mL cremophor oil (Cremophor EL,
polyethoxylated castor oil), 0.7 mL ethanol and 8 mL 0.9% saline
solution [23]. The injection volume range was standard (0.44–
0.5 mL) in each animal according to their weights (220–250 g).
Other reagents were purchased from Sigma-Aldrich Corporation
(St Louis, MO, USA).
Statistical analysis
Data are shown as means 6 SEM. Statistical analysis of data
was performed using IBM SPSS Statistics 20.0 software (IBM
Corporation, Armonk, NY, USA). Two-way analysis of variance
(ANOVA) was used for comparison of all groups with LSD post-
hoc tests. A 95% confidence interval was considered as statistically
significant (p,0.05).
Results
Determining skeletal muscle injury
Histopathology. As compared with the nearly normal
histological picture detectable in case of the Sham and NIM-
Sham groups, segmental necroses and disintegrated filaments were
observable in the muscle fibers in case of the IR group. The
muscle fibers were separated by significant edema. By contrast, in
the NIM-IR group, intact conditions were observable (Figure 1 A–
D).
Laboratory measurements. Both CK and LDH levels were
significantly increased in the IR group compared with the Sham
and NIM-Sham groups (values were almost similar in the latter
two groups). Both examined parameters were significantly lower in
the NIM-IR group than in the IR group (CK: p,0.001; LDH: p,
0.001). The serum K+ level was higher in the IR group compared
with the Sham and NIM-Sham groups, and the elevation was
significantly lower in the NIM-IR group (p = 0.017) (Figure 2 A–B,
Table 1).
Muscle fiber viability. In the IR group, muscle fiber
viability was significantly decreased as compared with the Sham
and NIM-Sham groups (where values were nearly 100 percent).
Viability in the NIM-IR group was significantly less reduced in
comparison with the IR group (p = 0.001) (Figure 2C, Table 1).
Wet/Dry ratio of skeletal muscle tissues. Calculations of
wet content of muscles revealed a significantly higher value in the
IR group as compared with the Sham and NIM-Sham groups. In
the NIM-IR group, the amount of tissue edema was significantly
lower than in the IR group (p = 0.014) (Figure 2D, Table 1).
Microcirculation of skeletal muscle of the lower
limb. Calculations of the reperfusion areas displayed signifi-
cantly compromised microcirculation observable in the IR group
when compared with the Sham and NIM-Sham groups.
Microcirculation became stabilized at a significantly higher level
in the NIM-IR group than in the IR group (RA: p,0.001)
(Figure 3A, Table 1).
Systemic parameters
Systemic hemodynamics. MAP values in case of the Sham
and NIM-Sham groups remained at the same level during the
entire experimental period. In case of both the IR and NIM-IR
group, the MAP values showed a decline by 30 and 32 mmHg,
respectively at the beginning of the reperfusion. After the
beginning of the reperfusion the MAP values were found to be
significantly higher in the NIM-IR group compared with the IR
group (p = 0.044) (Figure 3B, Table 1).
Measurement of TNF-a and IL-6 levels. Both TNF-a and
IL-6 levels were markedly increased in the IR group in comparison
with the Sham and NIM-Sham groups. The TNF-a level was
considerably lower in the NIM-IR group than in the IR group
(p = 0.003) (Figure 4A, Table 1). Regarding IL-6 measurements,
significantly lower levels were noticeable in the NIM-IR group
than in the IR group (p = 0.040). (Table 1).
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Determination of kidney dysfunction
Histopathology. In the IR group, swollen tubular cells,
intracellular vacuolization, disintegrated necrotic cells and blurred
cell borders were observable, as compared with the Sham and
NIM-Sham groups. The morphological picture of the kidney was
more favourable in the NIM-IR group, cell necrosis could rarely
be seen, intact cell borders and nearly normal cell morphology
were present. (Figure 1 E–H).
Figure 1. Muscle and kidney histopathology (hematoxillin-eosin (HE) stain, light microscopy). (A–B): An almost physiologically
histological picture is observable in the Sham (A) and NIM-Sham (B) groups, with intact muscle fibers and normal wide interstitial spaces. (C): In the IR
group segmental necrosis (circle), disintegrated myofilaments and thicker interstitial spaces (arrow) are detectable. (D): NIM-IR group shows intact
muscle fibers (circle) with no expanded interstitial spaces (arrow), similar to the normal structure. (E–F): Sham and NIM-Sham groups show the
normal structure of kidney cortical tissue. Tubules have normal appearance. (G): In the IR group massive injury can be detected with loss of cell
integrity and intracellular vacuolization (arrows). (H): In the NIM-IR group cell necrosis is less severe (arrow) and the tubular integrity remained intact
(circle), an almost normal picture can be seen.
doi:10.1371/journal.pone.0101067.g001
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The applied histopathological score was significantly lower in
the NIM-IR group, as compared with the IR group (p,0.001)
(Table 1).
Urine output and laboratory findings. Based on the urine
volume measured during the reperfusion, diuresis was significantly
lower in the IR group than in the Sham and NIM-Sham groups.
In the NIM-IR group, urine output was significantly higher when
compared with the IR group (p = 0.022) (Figure 5A, Table 1).
The serum creatinine level observable in the IR group was
significantly higher than the levels found in case of the Sham and
NIM-Sham groups. The level manifest in the NIM-IR group was
significantly less elevated than in case of the IR group (p = 0.001)
(Figure 5B, Table 1).
Calculated renal functional parameters. The fractional
Na+-excretion was significantly higher in the IR group compared
with the Sham and NIM-Sham groups. A significantly lower value
could be calculated in the NIM-IR group than in the IR group
(p,0.001) (Figure 5D, Table 1).
The serum BUN/creatinine ratio was lower in the IR and NIM-
IR groups compared with the Sham and NIM-Sham groups. No
statistically significant differences could be seen between the IR
and NIM-IR groups, though less decreased values were measured
in the latter group (Figure 5C, Table 1).
Renal microcirculation. After onset of reperfusion, the
microcirculatory flow rates of the IR and NIM-IR groups showed
a declining tendency in comparison with the Sham and NIM-
Sham groups; however, calculations of the reperfusion area (RA)
values did not point to any significant differences measurable
between the groups (Table 1).
Measurement of peroxynitrite concentrations in the
kidney. Significantly higher concentration of peroxynitrite
could be observed in the IR group when compared with the
Sham and NIM-Sham groups. In case of the NIM-IR group, such
Figure 2. Parameters of muscle injury, muscle fiber viability and muscle wet content. (A–B): Serum creatine-kinase (CK) and lactate-
dehydrogenase (LDH) concentrations were significantly elevated in the IR group compared with the Sham and NIM-Sham groups. Significantly lower
value was detectable in the NIM-IR group compared with the IR group, leading to the conclusion that there may be a lower extent of muscle necrosis
(CK: # p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,0.01 vs. IR; ` p,0.01 vs. Sham; & p,0.01 vs. NIM-Sham; LDH: # p,0.01 vs. Sham; { p,
0.01 vs. NIM-Sham; 1 p,0.01 vs. IR; ` p,0.01 vs. Sham; & p,0.01 vs. NIM-Sham; U/l – Unit/liter). (C): Muscle fiber viability was assessed by NADH-
tetrazolium staining and was expressed as percentage of viability measured in untreated controls (%). In the IR group there was a significant decline
in viability compared with the Sham and NIM-Sham groups. Significantly higher value was found in the NIM-IR group, compared with the IR group (#
p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,0.01 vs. IR; ` p,0.01 vs. Sham; & p,0.05 vs. NIM-Sham). (D): Wet/Dry ratio is suitable to determine
the amount of interstitial edema. The wet content of the skeletal muscle tissue was significantly lower in the NIM-IR group compared with the IR
group (# p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,0.05 vs. IR; ` p,0.05 vs. Sham; & p,0.05 vs. NIM-Sham).
doi:10.1371/journal.pone.0101067.g002
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elevation was preventable by administering NIM-811 (p,0.001)
(Figure 4B, Table 1).
Discussion
Acute limb ischemia is a sudden onset decline in the perfusion of
the limb, which is a serious concern regarding limb function and
even patient survival [24]. The aim of the present study was to set
up an experimental model and search for a therapeutic option
suitable for treatment of the postoperative complications of this
vascular disease. Several pharmacological interventions [25,26]
and surgical conditioning techniques [14,27] may be suitable
approaches to mitigate the IR injuries of the skeletal muscle [28].
CsA was widely investigated in previous studies during
ischemia-reperfusion [12]. In addition we can find papers in the
literature pertaining to the human usage of this drug in clinical
trials [29], but not in the clinical practice. The main problem with
this drug is its wide range adverse effects, as immunosuppression,
nephrotoxicity and hepatotoxicity. For this reason it is important
to find a medication which can prevent ischemic-reperfusion
injury without any severe adverse effects and additionally its usage
is simple, quick, effective and specific. Therein lies one of the main
novelties of our experiment.
The present study investigated the effects of the mPTP
inhibitor, NIM-811 after three hours of lower limb ischemia and
four hours of reperfusion in a rat model. MPTP opening has a
pivotal role in the development of IR injuries, triggering cell death
[30,31]. NIM-811 is a non-immunosuppressant derivative of CsA,
which is able to inhibit the opening of mPTP at the onset of
reperfusion, similarly to the effects of CsA [12]. Previous studies
[25,32–36] have shown that NIM-811 can reduce infarct size after
myocardial IR. Argaud et al. found that during 30 minutes of
ligation and 4 hours of reperfusion of the circumflex coronary
artery, CsA and NIM-811 pretreatment could significantly
decrease the extension of the necrotic area [25]. Lim et al.
investigated the effects of CsA in mice myocardial ischemic-
reperfusion model. They found that i.v. CsA treatment was
capable of reducing infarct size compared with placebo treated
controls following IR [37]. The favourable effects of CsA have
been successfully demonstrated in previous IR models [32–35] as
well as following lower limb IR [36]. Further investigations have
confirmed that both CsA and NIM-811 are able to attenuate
injuries of the skeletal muscle [26,38]. NIM-811 has not yet been
investigated in regard to its effects on the systemic and distant
organ impacts of these vascular diseases. Upon reviewing the
literature, no studies were found which investigate the effects of
this drug during lower limb skeletal muscle ischemia-reperfusion,
however rhabdomyolysis and its remote organ complications are
very common following vascular surgery of the lower limb arteries.
The present study is therefore quite novel in this field of vascular
surgical research. Moreover, mortality within 1 year following
revascularisation of acute limb ischemia may be 15–20 per cent
[39], which emphasizes the importance of our experiment.
There are only two publications in the literature so far reporting
that NIM-811 is effective during skeletal muscle IR after autogen
transplantation and replantation [26,38]. Our results support this
finding concerning the skeletal muscle. In the histological sections
of the IR group, apparent necrosis, muscle fiber disintegration and
edema were detectable in the muscles upon comparison with the
nearly normal muscle morphology of the NIM-IR group. Our
histological pictures are well supported by quantitatively with our
Table 1. Laboratory measurements, haemodynamics data and wet/dry ratios.
Sham NIM-Sham IR NIM-IR
P-value
(IR vs. NIM-IR)
Parameters
of muscle
injury
LDH (U/l) 153.40657.60 164.40615.19 1464.06143.82 832.56153.78 P,0.001
CK (U/l) 90.0636.24 95.60622.05 3632.226256.66 1530.336500.0 P,0.001
K+ (mmol/l) 4.060.56 4.2060.65 7.7960.96 6.5361.05 P = 0.017
Muscle fiber viability (%) 94.10615.0 90.0612.0 7.9465.71 36.97611.06 P = 0.001
W/D (%) 77.3560.36 77.4160.91 81.6460.89 79.1761.05 P = 0.014
LDF RA (%) 101.2362.63 91.9862.47 22.81614.86 45.43623.74 P,0.001
Systemic
parameters
TNF-a (pg/ml) 15.065.0 20.068.0 172.142625.0 55.34617.69 P = 0.003
IL-6 (pg/ml) 110.0625.0 125.0632.0 563.296120.0 224.736107.13 P = 0.040
MAP (during reperfusion; Hgmm) 102.1760.66 102.3263.67 88.0467.22 97.83611.47 P = 0.044
Parameters
of remote
kidney
injury
Histopathological score 1.0860.20 1.3360.25 4.060.81 2.6460.37 P,0.001
Urine output (during reperfusion; ml/h) 1.060.8 0.9560.10 0.0960.04 0.2760.07 P = 0.022
Creatinine (mmol/l) 79.14647.23 83.94619.37 150.17642.91 96.95632.21 P = 0.001
BUN/creatinine 0.0960.01 0.0960.01 0.0760.01 0.0960.01 N.S.
FENa (%) 0.2160.10 0.2260.12 1.2760.32 0.3260.15 P,0.001
LDF RA (%) 97.9061.76 90.8564.73 86.67615.63 83.01616.93 N.S.
Peroxynitrite (nmol/mg protein) 0.1560.03 0.1660.01 0.2460.02 0.1460.03 P,0.001
LDH: lactate dehydrogenase; CK: creatine kinase; W/D: wet/dry ratio; LDF RA: Laser Doppler flowmeter, reperfusion area; TNF-a: tumor necrosis factor alpha; IL-6:
interleukin 6; MAP: mean arterial pressure; BUN: blood urea nitrogen; FENa: fractional Na+ excretion.
doi:10.1371/journal.pone.0101067.t001
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Figure 3. Systemic hemodinamycs and microcirculation of skeletal muscle of lower limb. (A): Microcirculation of the lower limb skeletal
muscle was monitored by laser Doppler flowmeter (LDF). Data are shown as percentage of baseline flow before ischemia (%). In the IR group a
significant decline can be observed compared with the Sham and NIM-Sham groups after the onset of reperfusion. Microcirculation became
stabilized at a significantly higher level in the NIM-IR group than in the IR group (# p,0.05 vs. Sham; { p,0.05 vs. NIM-Sham; 1 p,0.05 vs. IR). (B):
Mean arterial pressure (MAP) was registered during blood pressure monitoring. MAP of the Sham and NIM-Sham groups remained constant during
the entire experimental period, whereas values of both the IR and NIM-IR groups decreased at the beginning of reperfusion. MAP of the NIM-IR group
was significantly higher after the onset of reperfusion as compared with the IR group (# p,0.05 vs. Sham; { p,0.05 vs. NIM-Sham; 1 p,0.05 vs. IR).
doi:10.1371/journal.pone.0101067.g003
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muscle fiber viability results. Nevertheless, Cheng et al. examined
the effect of NIM-811 in a rat small intestine IR model and in
agreement with our skeletal muscle findings, they found NIM-811
effective in attenuating intestinal IR injury. [40] During a three
hour long period of exclusion, rhabdomyolysis may develop, with
the release of different metabolites, necroenzymes and K+ into the
systemic circulation. Our study demonstrated that NIM-811 was
capable of reducing the serum levels of necroenzymes and ions,
which could be attributed to the lower extent of fiber disintegra-
tion possibly as the result of the inhibitory effect of NIM-811 on
the opening of mPTP. Our observations are consistent with
previous data, namely that both LDH level and rhabdomyolysis
could be significantly attenuated by different conditioning
techniques (preconditioning, postconditioning), as well as by
pretreatment with CsA and NIM-811 in an experimental model
of skeletal muscle IR [26].
During IR injury of the skeletal muscle, there is an increase in
vascular permeability, with the development of escalating intersti-
tial edema as a consequence of the extravascular presence of
plasma proteins [41]. Upon the effect of NIM-811 treatment,
significantly lower tissue wet content (edema) was measurable as
compared with the IR group. Our observations are in good
concordance with several other reports on the effects of CsA on
interstitial edema content of the skeletal muscle. Troitzsch et al.
studied the effects of CsA in an ischemia-reperfusion model of
rabbits. Ischemic period was 4 hours, followed by 2 hours of
reperfusion. The results of skeletal muscle W/D ratio supported
the decreased edema formation in the CsA treated group. [42].
Figure 4. Serum TNF-a and peroxynitrite concentration in the kidney. (A): Serum TNF-a concentration was significantly elevated in the IR
group, compared with the Sham and NIM-Sham groups. A significantly lower level was detected in the NIM-IR group compared with the IR group,
leading to the conclusion that there may be a lower extent of systemic inflammation (# p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,0.01 vs. IR; `
p.0.05 vs. Sham; & p.0.05 vs. NIM-Sham; pg/ml – pictogram/mililitre). (B): A significantly elevated peroxynitrite concentration can be observed in
homogenized kidney samples in the IR group, compared with the Sham and NIM-Sham groups. In the NIM-IR group, a significantly lower value was
measured compared with the IR group (# p,0.01 vs. Sham; { p,0.05 vs. NIM-Sham; 1 p,0.01 vs. IR).
doi:10.1371/journal.pone.0101067.g004
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Mitochondria play a central role in the pathophysiology of IR
injury, therefore NADH-tetrazolium enzyme histochemistry was
performed in our study for the more accurate detection of
subcellular muscle injury. This reaction is suitable for analysis of
the intactness of mitochondria and the viability of muscle fibers
[43]. With the use of NADH-tetrazolium enzyme histochemistry,
Mowlavi et al. demonstrated that CsA can induce substantially less
decrease in muscle fiber viability in a rat IR model compared with
a nontreated control group [44]. This result is also consistent with
our findings, namely, the NADH-tetrazolium reductase reaction of
active mitochondria was significantly higher in the NIM-IR group.
As NIM-811 is a specific drug for inhibition of mitochondrial
mPTPs, it can prevent the potentially fateful pore opening at onset
of reperfusion [25]. Inhibition of the pores can prevent the
changes in high-energy phosphate metabolism and mitochondrial
dysfunction [45], thereby the number of viable mitochondria
remains high. A previous study by Troitzsch et al. also indicated
that CsA treatment was capable of preserving the tissue viability
following skeletal muscle ischemia-reperfusion according to the
performed mitochondrial viability index [42].
In our experiment, we also studied the changes in microcircu-
lation of the rectus femoris muscle. During reperfusion, a
considerably higher flow was manifest in the NIM-811 treated
group than in the IR group. The conservation of cell structure
integrity may be in the background of this finding. Maintained
integrity of the cell structure results in lower degree of muscle cell
necrosis and tissue inflammation. As a consequence, less interstitial
wet content is present, which contributes to the mitigation of
microvascular external compression, thereby the appearance of
the ‘‘no-reflow’’ phenomenon is less likely [46]. The integrity of
microcirculation is of great importance as regards survival of the
limb during lower limb IR. Microcirculation is completely stopped
as the effect of total ischemia. It has been reported that after 4
hours of reperfusion, the capillary flow of skeletal muscle tissues is
decreased by 50 percent [47]. Rieber et al. demonstrated the
positive effect of CsA on the microcirculation of human ischemic
Figure 5. Renal function and calculated renal parameters. (A): Based on the measured urine output during reperfusion, diuresis is significantly
lower in the IR group compared to the Sham and NIM-Sham groups. In the NIM-IR group, urine output is significantly higher compared with the IR
group (# p,0.01 vs. Sham; { p,0.05 vs. NIM-Sham; 1 p,0.05 vs. IR; ` p,0.01 vs. Sham; & p.0.05 vs. NIM-Sham). (B): Serum creatinine level of the
IR group is significantly elevated compared with the Sham and NIM-Sham groups. The serum creatinine level of the NIM-IR group is significantly
lower compared with the IR group (# p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,0.05 vs. IR). (C): Serum BUN/creatinine ratio showed a lower
value compared with the Sham and NIM-Sham groups. In the NIM-IR group, a significantly increased value was detectable than in the IR group,
however the difference was not significant. (D): The fractional Na+-excretion is significantly increased in the IR group compared with the Sham and
NIM-Sham groups. There is a significantly lower value in the NIM-IR group than in the IR group (# p,0.01 vs. Sham; { p,0.01 vs. NIM-Sham; 1 p,
0.01 vs. IR).
doi:10.1371/journal.pone.0101067.g005
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heart following transplantation. This drug was capable of
preserving of microvasculature response which has impact on
long-term graft function after heart transplantation. [48].
In the background of the evolving systemic complications
following lower limb IR, generalization of the local inflammatory
process (SIRS) may play an important role [49]. The significant
changes taking place in the systemic circulation after a 3 hour long
period of exclusion underline the development of SIRS both in the
IR and NIM-IR groups. Different inflammatory mediators and
proinflammatory cytokines are released during the process. In our
experiment, TNF-a and IL-6 showed significantly lower values in
the NIM-IR group. The data of Squadrito et al. are in good
concordance with our results. These authors investigated the effect
of CsA after myocardial ischemia with the finding that it was able
to decrease the systemic TNF-a level and thereby the progression
of generalized inflammatory reaction [50].
Patients suffering from rhabdomyolysis are threatened by acute
kidney injury [51]. Miller et al. also demonstrated the linkage
between lower limb ischemia following vascular operation and
postoperative kidney injury. They supported their findings with
epidemiological evidences that ischemic rhabdomyolysis of the
skeletal muscle may be a major determining factor of renal failure
after thoracoabdominal aortic surgery. [52] In the current
experimental study, NIM-811 had primary effect on the mPTP
opening of lower limb skeletal muscle fibers and thereby an
indirect effect on remote kidney injury. Based on a similar
principle, Cour et al. investigated the effect of NIM-811 on the
kidneys in rabbits presenting post-cardiac arrest syndrome
following cardiac arrest and they demonstrated that the treatment
improved the short-term survival rates and kidney function [53].
Cast formation and tubular cell injury play central role in the
renal complications of rhabdomyolysis after lower limb IR. In the
present study, histological assessment of the kidneys demonstrated
acute tubular necrosis and intracellular vacuolization in the IR
group. By comparison, the NIM-IR group showed a more
favourable histological picture, also supported by the results of
the performed histological scoring of the kidney tissue.
Based on the results of the skeletal muscle viability and fiber
necrosis assessment, a lower degree of muscle damage developed
in the NIM-IR group, thus the release of metabolites and
inflammatory factors into the circulation was reduced. This could
be an explanation for the observed favourable histological picture
of the kidney.
The question arises regarding the direct effect of NIM-811 on
the mitochondria of the kidney, since this drug is used systemically,
however the main part of this pathophysiological process is the
skeletal muscle damage and consequently the releasing factors and
molecules which have damaging effect on the kidney. Therefore
the skeletal muscle should be considered as the therapeutic target.
Nevertheless our results on kidney microcirculation might support
that NIM-811 has no direct effect on the kidney.
Registration of the kidney microcirculation revealed diminished
blood flow in both the IR and NIM-IR groups after the onset of
reperfusion, which phenomenon has also been reported in the
literature after rhabdomyolysis [54]. In the current experimental
model, NIM-811 treatment had no effect on the microcirculatory
changes in the kidney, blood flow did not differ significantly
between the IR and the NIM-IR groups. The conclusion could be
drawn that NIM-811 pretreatment is able to reduce kidney injury
after lower limb exclusion, but the renal protective effect is not
exerted directly on the kidney.
Oxidative stress and the released free-radicals have important
roles in renal dysfunction following lower limb IR [54,55]. There
are two main pathways of forming free-radicals: by way of
oxidative and nitrosative reactions. Peroxynitrite (ONOO-) has
several deleterious effects on the cell [56–60]. In the current
experiment, accumulation of ONOO- in the kidney suggests
intensive production of nitrogen monoxide (NO) and development
of nitrosative stress. Besides measuring the formation of ONOO-
in our preliminary screening studies, we also investigated the level
of oxidative stress by means of measuring superoxide-dismutase
(SOD) and catalase (CAT) activities, as well as accumulation of
hydrogen peroxide (H2O2). Under the experimental conditions of
the current study, there were no significant changes in any of the
above parameters after IR (these data of preliminary studies are
unpublished). The unaltered SOD and CAT activities could be the
consequence of the fast depletion of O2˙
- through collision with NO
and the formation of an increased amount of ONOO-. This
implies that the damage caused by O2˙
- is mostly due to the rapid
accumulation of ONOO- and not to the formation of H2O2.
Formation of ONOO- was significantly reduced by administration
of NIM-811 in the NIM-IR group. This finding correlates with the
results of Packer et al., who showed that peroxynitrite induces the
opening of mPTP in isolated mitochondria and can lead to the
disturbance of cellular Ca2+ homeostasis, which contributes to cell
injury. CsA has been shown to prevent this process as well [61].
In the current experimental model, kidney injury after
rhabdomyolysis was determined predominantly by renal causes,
namely the appearance of acute tubular necrosis. Our histological
results and scoring showed that NIM-811 is capable of mitigating
the tubular damages. Based on these observations, we assessed the
indirect efficiency of NIM-811 treatment on the renal functions.
Urine output was significantly higher in the NIM-IR group and
this finding is independent from the fluid intake. Standard 5 ml/
bwkg/h continuous fluid infusion was given via jugular vein
cannula for each animal during the whole experiment. To take a
closer look at the renal function, we used calculated renal
parameters. The higher BUN/creatinine ratio observed in the
NIM-IR group could be explained by the lower levels of creatinine
and higher values of BUN. Urea is reabsorbed by tubular cells
after glomerular excretion, which does not occur when the tubular
cells are injured. We could therefore assume from the higher
BUN/creatinine ratio that less tubular cells were affected in the
NIM-IR group.
The fractional Na+-excretion is another easily calcualted
parameter for renal function. The majority of filtrated Na+ is
reabsorbed by the proximal tubular cells. A higher excretion of
Na+ in the urine represents impaired reabsorption, thus a more
severe damage of the tubular cells. NIM-811 has a favourable
effect on the tubular function, which is supported by the
significantly lower value of fractional Na+-excretion detected in
the NIM-IR group.
Conclusion
Our results demonstrated the favourable effect of NIM-811 on
skeletal muscle histology and necroenzyme release. Based on our
observations, NIM-811 can improve the viability of mitochondria
and the microcirculation and mitigates the interstitial wet content
in the injured muscle tissues of the lower limb. Systemic
inflammatory parameters proved the beneficial effects of this drug
on the development of systemic inflammatory reactions. Our
histological and laboratory evaluations of the renal function have
demonstrated the positive effect of NIM-811 on kidney injuries.
NIM-811 treatment was able to prevent and reduce rhabdo-
myolysis of the skeletal muscle and the remote kidney complica-
tions in our experimental model of lower limb arterial occlusive
diseases and IR injuries during vascular operations.
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